PT - JOURNAL ARTICLE AU - Jae-Won Hyun AU - Mark R Woodhall AU - Su-Hyun Kim AU - In Hye Jeong AU - Byungsoo Kong AU - Gayoung Kim AU - Yeseul Kim AU - Min Su Park AU - Sarosh R Irani AU - Patrick Waters AU - Ho Jin Kim TI - Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases AID - 10.1136/jnnp-2017-315998 DP - 2017 Oct 01 TA - Journal of Neurology, Neurosurgery & Psychiatry PG - 811--817 VI - 88 IP - 10 4099 - http://jnnp.bmj.com/content/88/10/811.short 4100 - http://jnnp.bmj.com/content/88/10/811.full SO - J Neurol Neurosurg Psychiatry2017 Oct 01; 88 AB - Background We evaluated the seroprevalence of myelin oligodendrocyte glycoprotein immunoglobulin G1 (MOG-IgG) and associated clinical features of patients from a large adult-dominant unselected cohort with mainly relapsing central nervous system (CNS) inflammatory diseases. We also investigate the clinical relevance of MOG-IgG through a longitudinal analysis of serological status over a 2-year follow-up period.Methods Serum samples from 505 patients with CNS inflammatory diseases at the National Cancer Center were analysed using cell-based assays for MOG-IgG and aquaporin-4 immunoglobulin G (AQP4-IgG). MOG-IgG serostatus was longitudinally assessed in seropositive patients with available serum samples and at least 2 years follow-up.Results Twenty-two of 505 (4.4%) patients with CNS inflammatory diseases were positive for MOG-IgG. Patients with MOG-IgG had neuromyelitis optica spectrum disorder (NMOSD, n=10), idiopathic AQP4-IgG-negative myelitis (n=4), idiopathic AQP4-IgG-negative optic neuritis (n=4), other demyelinating syndromes (n=3) and multiple sclerosis (n=1). No relapses were seen in patients when they became MOG-IgG seronegative, whereas a persistent positive serological status was observed in patients with clinical relapses despite immunotherapy.Conclusions In a large adult-predominant unselected cohort of mainly relapsing CNS inflammatory diseases, we confirmed that NMOSD phenotype was most commonly observed in patients with MOG-IgG. A longitudinal analysis with 2-year follow-up suggested that persistence of MOG-IgG is associated with relapses.